biospecimen__admin__batch_number	304.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	6
biospecimen__admin__dbgap_registration_code	000178
biospecimen__admin__disease_code	ACC
biospecimen__admin__file_uuid	19008C8F-11C1-40C5-9FBF-4872DD3633A2
biospecimen__admin__month_of_dcc_upload	11
biospecimen__admin__program	TCGA
biospecimen__admin__year_of_dcc_upload	2018
biospecimen__bio__bcr_analyte_barcode	TCGA-OR-A5L4-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-OR-A5L4-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-OR-A5L4-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632211
biospecimen__bio__day_of_creation	06
biospecimen__bio__day_of_shipment	08
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-OR-A5L4.B140F5B4-5B03-40EC-A5BB-BCF0963EC567.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A29S
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.08
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-OR-A5L4
biospecimen__shared__patient_id	A5L4
clinical__acc_shared__atypical_mitotic_figures	Atypical Mitotic Figures Absent
clinical__acc_shared__cytoplasm_presence_less_than_equal_25_percent	Cytoplasm presence <= 25% Present
clinical__acc_shared__diffuse_architecture	Diffuse Architecture Present
clinical__acc_shared__excess_adrenal_hormone_diagnosis_method_type	Both Clinical and Biochemical Assessments
clinical__acc_shared__excess_adrenal_hormone_history_type	Cortisol
clinical__acc_shared__invasion_of_tumor_capsule	Invasion of Tumor Capsule Present
clinical__acc_shared__mitotane_therapy	YES
clinical__acc_shared__mitotane_therapy_adjuvant_setting	YES
clinical__acc_shared__mitotic_rate	Mitotic Rate > 5/50 HPF Absent
clinical__acc_shared__necrosis	Necrosis Present
clinical__acc_shared__nuclear_grade_iii_iv	Nuclear Grade III or IV Present
clinical__acc_shared__sinusoid_invasion	Sinusoid Invasion Present
clinical__acc_shared__therapeutic_mitotane_levels_achieved	YES
clinical__acc_shared__therapeutic_mitotane_lvl_recurrence	NO
clinical__acc_shared__weiss_score	7
clinical__acc_shared__weiss_venous_invasion	Venous Invasion Present
clinical__admin__batch_number	304.64.0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	ACE34DD9-D415-4171-9646-C472F1474304
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__admin__year_of_dcc_upload	2016
clinical__clin_shared__age_at_initial_pathologic_diagnosis	48
clinical__clin_shared__bcr_followup_barcode	TCGA-OR-A5L4-F60529
clinical__clin_shared__bcr_followup_uuid	A04FA09A-9DCF-422A-9D0C-E794A23BF19C
clinical__clin_shared__ct_scan	YES
clinical__clin_shared__ct_scan_findings	Normal
clinical__clin_shared__day_of_form_completion	10
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__laterality	Right
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	No imaging evidence of disease
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__primary_therapy_outcome_success	Complete Remission/Response
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Adrenal
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__germline_testing_performed	NO
clinical__shared__histological_type	Adrenocortical carcinoma- Usual Type
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__clinical_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T4
gcm_curated__age	17819
gcm_curated__alt_biosample_source_id	TCGA-OR-A5L4-01A
gcm_curated__alt_donor_source_id	TCGA-OR-A5L4
gcm_curated__alt_item_source_id	TCGA-OR-A5L4-01A-11R-A29S-07
gcm_curated__assembly	GRCh38
gcm_curated__biological_replicate_count	1
gcm_curated__biological_replicate_number	1
gcm_curated__biosample_source_id	3be50768-a2b0-4498-a5e8-d5ba86e8680c
gcm_curated__biosample_type	tissue
gcm_curated__case_source_id	905368c2-ba60-4dda-b32d-a51a203b5e4d
gcm_curated__checksum	4b734dd6b1ecea333e61e52db3286ff1
gcm_curated__data_type	Gene Expression Quantification
gcm_curated__dataset_name	GRCh38_TCGA_gene_expression_2019_10
gcm_curated__date	2019-09-12T10:51:25.000000+02:00
gcm_curated__disease	Adrenocortical Carcinoma
gcm_curated__donor_source_id	905368c2-ba60-4dda-b32d-a51a203b5e4d
gcm_curated__ethnicity	white
gcm_curated__external_reference	https://portal.gdc.cancer.gov/cases/905368c2-ba60-4dda-b32d-a51a203b5e4d
gcm_curated__feature	gene expression
gcm_curated__file_format	BED
gcm_curated__file_name	67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq.bed
gcm_curated__gender	female
gcm_curated__is_annotation	false
gcm_curated__is_healthy	false
gcm_curated__item_source_id	67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq
gcm_curated__local_url	http://www.gmql.eu/gmql-rest/datasets/public.GRCh38_TCGA_gene_expression_2019_10/67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq/region
gcm_curated__pipeline	HTSeq - Counts, HTSeq - FPKM, HTSeq - FPKM-UQ
gcm_curated__project_name	TCGA-ACC
gcm_curated__replicate_source_id	3be50768-a2b0-4498-a5e8-d5ba86e8680c
gcm_curated__size	5018143
gcm_curated__source	TCGA
gcm_curated__source_page	https://portal.gdc.cancer.gov/files/2f8308c5-5ebd-49c2-953d-620176b66862,https://portal.gdc.cancer.gov/files/3c2ca272-e944-4386-b6d9-9b71900c16a0,https://portal.gdc.cancer.gov/files/af8cad34-72f9-46f2-be5a-929fe159b880
gcm_curated__source_site	University of Michigan
gcm_curated__source_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq.bed
gcm_curated__species	Homo sapiens
gcm_curated__technical_replicate_count	1
gcm_curated__technical_replicate_number	1_1
gcm_curated__technique	RNA-Seq
gcm_curated__tissue	Adrenal gland
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	67affce9-7c50-46c9-9f1c-f80c1dd9c888
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-OR-A5L4-01A-11R-A29S-07
gdc__aliquots__updated_datetime	2018-11-28T09:15:35.577429-06:00
gdc__analysis__analysis_id	10115378-89ae-460e-a7a7-922b2fe81aef,0d2f21b6-927f-47b8-bf28-a738a277b568,b1a9ded9-fd99-4c69-a18b-3baae78c6f30
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - Counts,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	20ed4b7f-0d71-46a7-8137-d0bdfed46dbf
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__concentration	0.16
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	905368c2-ba60-4dda-b32d-a51a203b5e4d
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:51:46.436074-05:00,2016-05-29T10:51:46.065268-05:00,2016-05-29T10:51:46.238227-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__age_at_index	48
gdc__demographic__days_to_birth	-17819
gdc__demographic__demographic_id	990a9650-99ee-518b-824e-cbcc81ba431b
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__vital_status	Alive
gdc__demographic__year_of_birth	1963
gdc__diagnoses__age_at_diagnosis	17819
gdc__diagnoses__ajcc_clinical_m	M0
gdc__diagnoses__ajcc_pathologic_n	N0
gdc__diagnoses__ajcc_pathologic_t	T4
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_diagnosis	0
gdc__diagnoses__days_to_last_follow_up	967
gdc__diagnoses__diagnosis_id	daede443-5bcb-57a9-aea7-501295b3f32b
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8370/3
gdc__diagnoses__primary_diagnosis	Adrenal cortical carcinoma
gdc__diagnoses__prior_malignancy	no
gdc__diagnoses__prior_treatment	No
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Cortex of adrenal gland
gdc__diagnoses__tissue_or_organ_of_origin	Cortex of adrenal gland
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iii
gdc__diagnoses__year_of_diagnosis	2011
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__alcohol_history	Not Reported
gdc__exposures__exposure_id	86785a27-aee0-5331-940a-855d747801d0
gdc__file_id	2f8308c5-5ebd-49c2-953d-620176b66862,3c2ca272-e944-4386-b6d9-9b71900c16a0,af8cad34-72f9-46f2-be5a-929fe159b880
gdc__file_name	1e0dd81a-566f-4806-b346-96da43a1456c.FPKM.txt.gz,1e0dd81a-566f-4806-b346-96da43a1456c.htseq.counts.gz,1e0dd81a-566f-4806-b346-96da43a1456c.FPKM-UQ.txt.gz
gdc__file_size	480360,243726,481762
gdc__input_files__access	controlled
gdc__input_files__data_category	Sequencing Reads
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__file_id	1d3534e1-ce58-41b7-8dcf-05aeee0d95ff
gdc__input_files__file_name	d2b8c1e2-e5b8-48cb-9d69-4b51af9cc75f_gdc_realn_rehead.bam
gdc__input_files__file_size	5656705152
gdc__input_files__md5sum	372989b388fe64e9967735ce5faaf277
gdc__input_files__platform	Illumina
gdc__md5sum	921f3a2873e66fda62f1ec12c498092a,83b955f04fe4733aced4302163a444b6,c58419c00c15f3fe47675c38c2a26e9f
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6da654c2-9e3a-46d7-a973-703d9beb7d99
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Adrenal gland
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Adrenocortical Carcinoma
gdc__project__project_id	TCGA-ACC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	456
gdc__samples__initial_weight	80.0
gdc__samples__is_ffpe	false
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	B140F5B4-5B03-40EC-A5BB-BCF0963EC567
gdc__samples__sample_id	3be50768-a2b0-4498-a5e8-d5ba86e8680c
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__samples__tissue_type	Not Reported
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	5.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	5.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	b83aba93-f744-4816-9d13-f5cc8a8453db
gdc__submitter_id	1e0dd81a-566f-4806-b346-96da43a1456c_fpkm,1e0dd81a-566f-4806-b346-96da43a1456c_count,1e0dd81a-566f-4806-b346-96da43a1456c_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	OR
gdc__tissue_source_site__name	University of Michigan
gdc__tissue_source_site__tissue_source_site_id	2ff9cebf-b83f-5ec2-aae4-3aa1bf1bb02d
gdc__treatments__treatment_id	c34cea79-7857-53a9-b079-a8bde171f0be
gdc__treatments__treatment_or_therapy	yes
gdc__treatments__treatment_type	Pharmaceutical Therapy, NOS,Pharmaceutical Therapy, NOS
gdc__type	gene_expression
gdc__updated_datetime	2019-09-18T14:38:42.659845+00:00
manually_curated__data_format	BED
manually_curated__download_date	2019-11-05T21:19:07.558+01:00
manually_curated__exp_data_bed_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq.bed
manually_curated__exp_metadata_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5018144
manually_curated__local_md5	da9893487ae76f8754a156fb13594bc8
manually_curated__opengdc_download_date	2019-09-12T10:51:25.000000+02:00
manually_curated__opengdc_file_md5	4b734dd6b1ecea333e61e52db3286ff1
manually_curated__opengdc_file_size	5018143
manually_curated__opengdc_id	67affce9-7c50-46c9-9f1c-f80c1dd9c888-geq
manually_curated__origin_file_size	5018143
manually_curated__origin_last_modified_date	Mon Sep 30 16:53:00 CEST 2019
manually_curated__origin_md5	4b734dd6b1ecea333e61e52db3286ff1
manually_curated__tissue_status	tumoral
